Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci.

Hajdarevic, Riad; Lande, Asgeir; Rekeland, Ingrid; Rydland, Anne; Strand, Elin B; Sosa, Daisy D; Creary, Lisa E; Mella, Olav; Egeland, Torstein; Saugstad, Ola D; Fluge, Øystein; Lie, Benedicte A; Viken, Marte K

Hajdarevic, Riad; Lande, Asgeir; Rekeland, Ingrid; Rydland, Anne; Strand, Elin B; Sosa, Daisy D; Creary, Lisa E; Mella, Olav; Egeland, Torstein; Saugstad, Ola D; Fluge, Øystein; Lie, Benedicte A; Viken, Marte K.

Afiliação

Hajdarevic R; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: riad.hajdarevic@medisin.uio.no.
Lande A; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Rekeland I; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Rydland A; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Strand EB; CFS/ME Center, Oslo University Hospital, Oslo, Norway; Faculty of Health, VID Specialized University, Stavanger, Norway.
Sosa DD; CFS/ME Center, Oslo University Hospital, Oslo, Norway; National Advisory Unit on CFS/ME, Oslo, Norway.
Creary LE; Department of Pathology, Stanford University, School of Medicine, Palo Alto, CA, USA; Histocompatibility and Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
Mella O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Norway.
Egeland T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Saugstad OD; Department of Pediatric Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Norway.
Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Viken MK; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway. Electronic address: m.k.viken@ous-research.no.

Brain Behav Immun ; 98: 101-109, 2021 11.

Article em En | MEDLINE | ID: mdl-34403736

Assuntos

Síndrome de Fadiga Crônica; Alelos; Canadá; Síndrome de Fadiga Crônica/genética; Antígenos HLA; Antígenos HLA-DQ/genética; Humanos; Complexo Principal de Histocompatibilidade; Valina-tRNA Ligase

Palavras-chave

HLA fine-mapping; Human leukocyte antigen; ME/CFS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Brain Behav Immun Assunto da revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google